Terumo (OTCMKTS:TRUMY) Shares Gap Up – Here’s What Happened

Terumo Corp. (OTCMKTS:TRUMY – Get Free Report)’s share price gapped up before the market opened on Monday. The stock had previously closed at $14.6785, but opened at $15.2450. Terumo shares last traded at $15.32, with a volume of 7,606 shares trading hands.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on TRUMY. Zacks Research upgraded Terumo from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 13th. Nomura upgraded Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. Two analysts have rated the stock with a Strong Buy rating. Based on data from MarketBeat.com, the company has an average rating of “Strong Buy”.

Read Our Latest Stock Analysis on Terumo

Terumo Trading Up 1.8%

The company has a quick ratio of 1.37, a current ratio of 2.19 and a debt-to-equity ratio of 0.13. The stock’s 50 day moving average is $14.80 and its two-hundred day moving average is $14.09. The company has a market capitalization of $22.60 billion, a PE ratio of 31.92 and a beta of 0.82.

Terumo (OTCMKTS:TRUMY – Get Free Report) last posted its earnings results on Thursday, November 12th. The company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.06). Terumo had a net margin of 9.31% and a return on equity of 7.03%. The business had revenue of $1.96 billion for the quarter, compared to analysts’ expectations of $1.94 billion. As a group, sell-side analysts predict that Terumo Corp. will post 0.86 EPS for the current fiscal year.

About Terumo

(Get Free Report)

Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

Recommended Stories

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.